Microvascular Obstruction in Patients With Anterior STEMI Treated With Supersaturated Oxygen

Area of Science:

• Cardiology
• Interventional Cardiology
• Biomedical Engineering

Background:

• ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring timely intervention.
• Percutaneous coronary intervention (PCI) is a standard treatment for STEMI.
• The role of supersaturated oxygen (SSO2) in mitigating microvascular obstruction (MVO) post-PCI for anterior STEMI remains under investigation.

Purpose of the Study:

• To evaluate the impact of SSO2 therapy on MVO in patients with anterior STEMI undergoing primary PCI.
• To compare MVO extent and presence in patients treated with SSO2 versus those who did not receive SSO2.

Main Methods:

• An individual patient data pooled analysis included 874 patients with anterior STEMI who underwent MVO assessment via cardiac magnetic resonance imaging within 10 days of primary PCI.
• Ninety patients (10.3%) received SSO2 therapy.
• The primary endpoint was the extent of MVO, analyzed using a weighted multivariable model; the secondary endpoint was the presence of MVO.

Main Results:

• SSO2 therapy was independently associated with a lower extent of MVO (coefficient, -1.35; P = .03).
• A borderline statistically significant reduction in the risk of any MVO was observed with SSO2 therapy (adjusted odds ratio, 0.56; P = .051).

Conclusions:

• SSO2 therapy demonstrated a significant association with reduced MVO after successful primary PCI in anterior STEMI patients.
• These findings support the potential benefit of SSO2 in improving myocardial recovery and reducing infarct size in STEMI.
• Further research may solidify SSO2 as an adjunctive therapy in STEMI management.